TheraRadar
Clinical-Stage Companies / DualityBio

DualityBio

Pre-Approval PRO BETA
11
Total Trials
2
Phase 3
8
Phase 2
10
Recruiting
133
Score

Pipeline by Phase

Phase 3
2
Phase 2
8
Phase 1
8

Therapeutic Focus

Advanced Solid Tumor Advanced/Metastatic Solid Tumors Solid Tumor, Adult Metastatic Breast Cancer Solid Tumors

Clinical Trials (11)

NCT06018337 Phase 3 ACTIVE NOT RECRUITING

A Study of DB-1303/BNT323 vs Investigator's Choice Chemotherapy in HER2-Low, Hormone Receptor Positive Metastatic Breast Cancer (DYNASTY-Breast02)

Started: 1/18/2024

NCT06265428 Phase 3 ACTIVE NOT RECRUITING

A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

Started: 1/29/2024

NCT06953089 Phase 2 RECRUITING

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

Started: 7/18/2025

NCT07141706 Phase 1 RECRUITING

A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors

Started: 9/23/2025

NCT05785741 Phase 1 RECRUITING

A Study of DB-1310 in Advanced/Metastatic Solid Tumors

Started: 8/17/2023

NCT06554795 Phase 1 RECRUITING

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Started: 9/3/2024

NCT05150691 Phase 1 RECRUITING

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Started: 1/31/2022

NCT06625671 Phase 1 RECRUITING

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE Participants

Started: 10/4/2024

NCT05914116 Phase 1 RECRUITING

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Started: 8/17/2023

NCT05438329 Phase 1 RECRUITING

First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors

Started: 7/19/2022

NCT07263594 Phase 1 NOT YET RECRUITING

A Study of DB-1324 in Advanced/Metastatic Gastrointestinal Tumors

Started: 12/1/2025

Drug Candidates

DB-1317 DB-1310 Trastuzumab Osimertinib capecitabine DB-1419 DB-1303/BNT323 Capecitabine Paclitaxel Nab-paclitaxel
Activity Status: Active
Last Trial Started: 12/1/2025
Last Trial Ended: N/A
Trials (12 months): 3
Completed Trials: 0
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.